Details of Protein
General Information of Protein (ID: PRT01352) | |||||
---|---|---|---|---|---|
Name | Forkhead box protein O1 (FOXO1) | ||||
Synonyms |
Click to Show/Hide Synonyms of This Protein
A; Forkhead in rhabdomyosarcoma; Foxo1; Fkhr; Foxo1a
|
||||
Gene Name | Foxo1 | Gene ID | |||
UniProt ID | |||||
Family | Transcription factor (TF) | ||||
Click to Show/Hide the Molecular/Functional Data (Sequence/Structure/Function) of This Protein | |||||
Sequence |
MAEAPQVVETDPDFEPLPRQRSCTWPLPRPEFNQSNSTTSSPAPSGGAAANPDAAASLAS
ASAVSTDFMSNLSLLEESEDFARAPGCVAVAAAAAASRGLCGDFQGPEAGCVHPAPPQPP PTGPLSQPPPVPPSAAAAAGPLAGQPRKTSSSRRNAWGNLSYADLITKAIESSAEKRLTL SQIYEWMVKSVPYFKDKGDSNSSAGWKNSIRHNLSLHSKFIRVQNEGTGKSSWWMLNPEG GKSGKSPRRRAASMDNNSKFAKSRGRAAKKKASLQSGQEGPGDSPGSQFSKWPASPGSHS NDDFDNWSTFRPRTSSNASTISGRLSPIMTEQDDLGDGDVHSLVYPPSAAKMASTLPSLS EISNPENMENLLDNLNLLSSPTSLTVSTQSSPGSMMQQTPCYSFAPPNTSLNSPSPNYSK YTYGQSSMSPLPQMPMQTLQDSKSSYGGLNQYNCAPGLLKELLTSDSPPHNDIMSPVDPG VAQPNSRVLGQNVMMGPNSVMPAYGSQASHNKMMNPSSHTHPGHAQQTASVNGRTLPHVV NTMPHTSAMNRLTPVKTPLQVPLSHPMQMSALGSYSSVSSCNGYGRMGVLHQEKLPSDLD GMFIERLDCDMESIIRNDLMDGDTLDFNFDNVLPNQSFPHSVKTTTHSWVSG |
||||
Function | Transcription factor that is the main target of insulin signaling and regulates metabolic homeostasis in response to oxidative stress. Binds to the insulin response element (IRE) with consensus sequence 5'-TT[G/A]TTTTG-3' and the related Daf-16 family binding element (DBE) with consensus sequence 5'-TT[G/A]TTTAC-3'. Activity suppressed by insulin. Main regulator of redox balance and osteoblast numbers and controls bone mass. Orchestrates the endocrine function of the skeleton in regulating glucose metabolism. Also acts as a key regulator of chondrogenic commitment of skeletal progenitor cells in response to lipid availability: when lipids levels are low, translocates to the nucleus and promotes expression of SOX9, which induces chondrogenic commitment and suppresses fatty acid oxidation. Acts synergistically with ATF4 to suppress osteocalcin/BGLAP activity, increasing glucose levels and triggering glucose intolerance and insulin insensitivity. Also suppresses the transcriptional activity of RUNX2, an upstream activator of osteocalcin/BGLAP. In hepatocytes, promotes gluconeogenesis by acting together with PPARGC1A and CEBPA to activate the expression of genes such as IGFBP1, G6PC1 and PCK1. Important regulator of cell death acting downstream of CDK1, PKB/AKT1 and STK4/MST1. Promotes neural cell death. Mediates insulin action on adipose tissue. Regulates the expression of adipogenic genes such as PPARG during preadipocyte differentiation and, adipocyte size and adipose tissue-specific gene expression in response to excessive calorie intake. Regulates the transcriptional activity of GADD45A and repair of nitric oxide-damaged DNA in beta-cells. Required for the autophagic cell death induction in response to starvation or oxidative stress in a transcription-independent manner. Mediates the function of MLIP in cardiomyocytes hypertrophy and cardiac remodeling. Regulates endothelial cell (EC) viability and apoptosis in a PPIA/CYPA-dependent manner via transcription of CCL2 and BCL2L11 which are involved in EC chemotaxis and apoptosis. | ||||
Regulatory Network | |||||
Full List of Metabolite(s) Regulated by This Protein | ||||||
---|---|---|---|---|---|---|
Nucleosides, nucleotides, and analogues | ||||||
CMP-N-Acetylneuraminate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | CMP-N-Acetylneuraminate concentration: increase (FC = 1.20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of CMP-N-acetylneuraminate levels compared with control group. | |||||
DTDP-alpha-D-glucose(2-) | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | DTDP-alpha-D-glucose(2-) concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of DTDP-alpha-D-glucose(2-) levels compared with control group. | |||||
GDP-glucose | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | GDP-glucose concentration: increase (FC = 1.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of GDP-glucose levels compared with control group. | |||||
Guanosine monophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Guanosine monophosphate concentration: increase (FC = 1.20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of guanosine monophosphate levels compared with control group. | |||||
NAD | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | NAD concentration: decrease (FC = 0.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of NAD levels compared with control group. | |||||
UDP-GalNAc | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | UDP-GalNAc concentration: decrease (FC = 0.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of UDP-GalNAc levels compared with control group. | |||||
Benzenoids | ||||||
Rhein | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Rhein concentration: increase (FC = 1.20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of rhein levels compared with control group. | |||||
Lipids and lipid-like molecules | ||||||
Glycerol 3-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glycerol 3-phosphate concentration: increase (FC = 1.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of glycerol 3-phosphate levels compared with control group. | |||||
Glycerophosphocholine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glycerophosphocholine concentration: decrease (FC = 0.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of glycerophosphocholine levels compared with control group. | |||||
Organic acids | ||||||
OSuccinylhomoserine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | OSuccinylhomoserine concentration: increase | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of o-succinylhomoserine levels compared with control group. | |||||
Organic acids and derivatives | ||||||
1-Methylhistidine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 1-Methylhistidine concentration: decrease (FC = 0.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of 1-methylhistidine levels compared with control group. | |||||
2-Aminoisobutyric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 2-Aminoisobutyric acid concentration: decrease (FC = 0.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of 2-aminoisobutyric acid levels compared with control group. | |||||
4-Guanidinobutanoic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 4-Guanidinobutanoic acid concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of 4-guanidinobutanoic acid levels compared with control group. | |||||
4-Hydroxyproline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 4-Hydroxyproline concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of 4-hydroxyproline levels compared with control group. | |||||
Alanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Alanine concentration: decrease (FC = 0.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of alanine levels compared with control group. | |||||
Arginine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Arginine concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of arginine levels compared with control group. | |||||
Argininosuccinic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Argininosuccinic acid concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of argininosuccinic acid levels compared with control group. | |||||
Aspartic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Aspartic acid concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of aspartic acid levels compared with control group. | |||||
Beta-Alanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Beta-Alanine concentration: decrease (FC = 0.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of beta-alanine levels compared with control group. | |||||
DL-O-Phosphoserine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | DL-O-Phosphoserine concentration: decrease (FC = 0.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of DL-O-Phosphoserine levels compared with control group. | |||||
Fumaric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Fumaric acid concentration: increase (FC = 1.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of fumaric acid levels compared with control group. | |||||
Gamma-Aminobutyric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Gamma-Aminobutyric acid concentration: decrease (FC = 0.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of gamma-aminobutyric acid levels compared with control group. | |||||
Glutamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glutamine concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of glutamine levels compared with control group. | |||||
Glutathione | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glutathione concentration: decrease (FC = 0.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of glutathione levels compared with control group. | |||||
Glycine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glycine concentration: decrease (FC = 0.90) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of glycine levels compared with control group. | |||||
Guanidoacetic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Guanidoacetic acid concentration: decrease (FC = 0.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of guanidoacetic acid levels compared with control group. | |||||
Histidine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Histidine concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of histidine levels compared with control group. | |||||
Hypotaurine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Hypotaurine concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of hypotaurine levels compared with control group. | |||||
Lysine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Lysine concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of lysine levels compared with control group. | |||||
Malic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Malic acid concentration: increase (FC = 1.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of malic acid levels compared with control group. | |||||
Melilotocarpan A | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Melilotocarpan A concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of melilotocarpan A levels compared with control group. | |||||
Methionine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Methionine concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of methionine levels compared with control group. | |||||
Methionine sulfoxide | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Methionine sulfoxide concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of methionine sulfoxide levels compared with control group. | |||||
N-Acetylserine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | N-Acetylserine concentration: increase (FC = 1.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of N-acetylserine levels compared with control group. | |||||
Ophthalmic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Ophthalmic acid concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of ophthalmic acid levels compared with control group. | |||||
Ornithine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Ornithine concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of ornithine levels compared with control group. | |||||
Phenylalanine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Phenylalanine concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of phenylalanine levels compared with control group. | |||||
Phosphocreatine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Phosphocreatine concentration: decrease (FC = 0.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of phosphocreatine levels compared with control group. | |||||
Phosphoenolpyruvate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Phosphoenolpyruvate concentration: increase (FC = 1.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of phosphoenolpyruvate levels compared with control group. | |||||
Threonine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Threonine concentration: decrease (FC = 0.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of threonine levels compared with control group. | |||||
Tyrosine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Tyrosine concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of tyrosine levels compared with control group. | |||||
Organic nitrogen compounds | ||||||
Beta-Guanidinopropionic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Beta-Guanidinopropionic acid concentration: decrease (FC = 0.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of beta-Guanidinopropionic acid levels compared with control group. | |||||
Carnitine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Carnitine concentration: increase (FC = 1.20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of carnitine levels compared with control group. | |||||
Choline | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Choline concentration: increase (FC = 1.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of choline levels compared with control group. | |||||
Ethanolamine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Ethanolamine concentration: increase (FC = 1.30) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of ethanolamine levels compared with control group. | |||||
Phosphorylcholine | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Phosphorylcholine concentration: decrease (FC = 0.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of phosphorylcholine levels compared with control group. | |||||
Organic oxygen compounds | ||||||
2,3-Bisphosphoglycerate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 2,3-Bisphosphoglycerate concentration: increase (FC = 1.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of 2,3-bisphosphoglycerate levels compared with control group. | |||||
3-Phosphoglyceric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 3-Phosphoglyceric acid concentration: increase (FC = 1.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of 3-phosphoglyceric acid levels compared with control group. | |||||
6-Phosphogluconic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 6-Phosphogluconic acid concentration: increase (FC = 1.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of 6-phosphogluconic acid levels compared with control group. | |||||
D-Ribose 5-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | D-Ribose 5-phosphate concentration: increase (FC = 2.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of D-Ribose 5-phosphate levels compared with control group. | |||||
D-Ribulose 5-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | D-Ribulose 5-phosphate concentration: increase (FC = 2.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of D-Ribulose 5-phosphate levels compared with control group. | |||||
D-Sedoheptulose 7-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | D-Sedoheptulose 7-phosphate concentration: increase (FC = 2.90) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of D-sedoheptulose 7-phosphate levels compared with control group. | |||||
Dihydroxyacetone phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Dihydroxyacetone phosphate concentration: increase (FC = 8.10) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of dihydroxyacetone phosphate levels compared with control group. | |||||
Fructose 6-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Fructose 6-phosphate concentration: increase (FC = 4.20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of fructose 6-phosphate levels compared with control group. | |||||
Gluconic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Gluconic acid concentration: increase (FC = 2.00) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of gluconic acid levels compared with control group. | |||||
Glucose 1-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glucose 1-phosphate concentration: increase (FC = 1.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of glucose 1-phosphate levels compared with control group. | |||||
Glucose 6-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glucose 6-phosphate concentration: increase (FC = 3.10) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of glucose 6-phosphate levels compared with control group. | |||||
Glyceraldehyde 3-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Glyceraldehyde 3-phosphate concentration: increase (FC = 6.30) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of glyceraldehyde 3-phosphate levels compared with control group. | |||||
myo-Inositol 1-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | myo-Inositol 1-phosphate concentration: increase (FC = 1.30) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of myo-inositol 1-phosphate levels compared with control group. | |||||
N-Acetyl-glucosamine 1-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | N-Acetyl-glucosamine 1-phosphate concentration: decrease (FC = 0.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of N-acetyl-glucosamine 1-phosphate levels compared with control group. | |||||
Pantothenic acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Pantothenic acid concentration: decrease (FC = 0.30) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of pantothenic acid levels compared with control group. | |||||
Phosphoribosyl pyrophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Phosphoribosyl pyrophosphate concentration: increase (FC = 1.80) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of phosphoribosyl pyrophosphate levels compared with control group. | |||||
Sorbitol-6-phosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Sorbitol-6-phosphate concentration: increase (FC = 1.40) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of sorbitol-6-phosphate levels compared with control group. | |||||
Organoheterocyclic compounds | ||||||
1-Methylnicotinamide | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | 1-Methylnicotinamide concentration: decrease (FC = 0.60) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of 1-methylnicotinamide levels compared with control group. | |||||
Thiamine pyrophosphate | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Thiamine pyrophosphate concentration: increase (FC = 1.20) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of thiamine pyrophosphate levels compared with control group. | |||||
Tryptophan | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Tryptophan concentration: decrease (FC = 0.50) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the decrease of tryptophan levels compared with control group. | |||||
Uric acid | Click to Show/Hide the Full List of Regulating Pair(s): 1 Pair(s) | |||||
Detailed Information |
Metabo Info
![]() |
|||||
Regulating Pair |
Experim Info
![]() |
[1] | ||||
Introduced Variation | Overexpression of Foxo1 | |||||
Induced Change | Uric acid concentration: increase (FC = 2.70) | |||||
Summary | Introduced Variation
![]() ![]() ![]() |
|||||
Disease Status | Healthy individual | |||||
Details | It is reported that overexpression of Foxo1 leads to the increase of uric acid levels compared with control group. | |||||
References | |||||
---|---|---|---|---|---|
1 | Metabolomic analysis of C2C12 myoblasts induced by the transcription factor FOXO1. FEBS Lett. 2019 Jun;593(12):1303-1312. |
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.